Highlights d Site-specifically, C-terminally phosphorylated purified Akt1 forms were analyzed 
In Brief
Dissecting the molecular interactions leading to Akt activation points to a chain of events distinct from existing models.
INTRODUCTION
The protein Ser/Thr kinase Akt1 (a.k.a. Akt, protein kinase B) and its two paralogs Akt2 and Akt3 have been intensively studied in cancer and metabolism (Manning and Toker, 2017) . Akt1 is a key component of the phospholipid PIP3 (phosphatidyl inositol 3,4,5-triphosphate) signaling network (Fruman et al., 2017) . In this network, the levels of PIP3 are controlled by the opposing actions of PI3-kinase and PTEN phosphatase (Fruman et al., 2017) . Activation of PI3-kinase by growth factor receptor stimulation or mutation drives PIP2 to PIP3 conversion (Fruman et al., 2017) . In the classical model of Akt1 regulation, phospholipid PIP3 recruits Akt1 to the plasma membrane (James et al., 1996) where it is acted upon by two protein kinases, mTORC2 and PDK1, which phosphorylate Akt1 on its C terminus (Ser473) and activation loop (Thr308), respectively (Alessi et al., 1996 (Alessi et al., , 1997 Sarbassov et al., 2005) . Dual phosphorylation of Akt1 leads to its enhanced kinase activity that targets protein substrates including GSK3 and Foxo1/3a (Manning and Toker, 2017) . Akt1 activity can promote cell growth, block apoptosis, and mediate insulin response (Manning and Toker, 2017) , and Akt1 inhibitors are in clinical development including ATP-site and allosteric site binding compounds (Crabb et al., 2017; Larsen et al., 2017) .
Akt1-Akt3 belong to the 60+ member AGC family of protein kinases (Leroux et al., 2018; Pearce et al., 2010) many of which are also regulated by activation loop and C-terminal phosphorylation. In some AGC enzymes, the C-terminal phosphorylation site appears to be naturally substituted with an acidic Asp residue and S473D has been reported to simulate the pSer473 state of Akt1 (Alessi et al., 1996; Pearce et al., 2010; Pearlman et al., 2011; Yang et al., 2002a Yang et al., , 2002b . Unlike most AGC kinases, Akt1-Akt3 possess a pleckstrin homology (PH) domain that shows high affinity for PIP3 (Manning and Toker, 2017; Milburn et al., 2003) . The Akt1-Akt3 domain architecture includes an N-terminal PH domain followed by an unstructured linker, a conserved kinase domain, and a flexible C-terminal regulatory domain (Manning and Toker, 2017) (Figure 1A ).
The molecular mechanism of Akt1-Akt3 regulation by C-terminal phosphorylation has been investigated previously (Alessi et al., 1996; Calleja et al., 2009; Yang et al., 2002a Yang et al., , 2002b ). An X-ray crystal structure has been reported of an Akt1 form (aa144-480, D143-Akt1) lacking the PH and linker regions but possessing pThr 308 and an Asp473 phospho-mimic in a ternary complex with a peptide substrate and nucleotide analog AMPPNP (Yang et al., 2002a) . In this structure, the Akt1 C-terminal region interacts with the N lobe of the kinase domain, apparently driving an active conformation. Consistent with this idea, an X-ray structure of the Akt1 kinase domain with a C-terminal deletion shows an inactive Akt1 conformation (Yang et al., 2002b ). An X-ray structure of an Akt1 form containing the PH domain but lacking the C terminus (aa1-443) in complex with allosteric inhibitor VIII displays an inactive kinase conformation involving an intramolecular interaction between the kinase and PH domains (Wu et al., 2010) . It has been unclear how important the PH domain might be in Akt1 autoinhibition because C-terminal deletion itself appears to facilitate formation of the inactive state, and the presence of VIII may have induced the PH-kinase domain interaction. It has recently been reported, however, that PIP3 can activate Akt by PH domain engagement (Ebner et al., 2017) . Beyond the well-established Ser473 phosphorylation, it has been discovered that Akt1 can be concurrently phosphorylated in cells on Ser477 and Thr479 by Cdk2/cyclinA2 (Liu et al., 2014) . Ser477 and Thr479 phosphorylation have been proposed to turn on Akt1 in the cell nucleus and facilitate cell-cycle progression. The mechanism of Akt1 activation by these noncanonical C-terminal phosphorylations, studied with Asp/Glu substitutions and peptide complementation experiments has been suggested to mimic that of Ser473 phosphorylation (Liu et al., 2014) .
In addition, the influence of C-terminal phosphorylation on Thr308 phosphorylation in Akt1 has been uncertain. Based on cell-based experiments, it has been suggested that prior phosphorylation of Ser473 may stimulate phosphorylation of Thr308 (Guo et al., 2014) , although this was not observed in other studies (Alessi et al., 1996; Jacinto et al., 2006) .
A limitation in the analysis of Akt1 regulation has been the absence of purified Akt containing the desired phospho-modifications. pThr 308 can be reliably installed using PDK1 (Gao et al., 2005) but purified Akt1 with specific C-terminal phosphorylations has not yet been reported. Here, we use expressed protein ligation to generate the desired Akt1 phospho-forms. Expressed protein ligation is a method of protein semisynthesis involving the chemoselective reaction between a recombinant protein C-terminal thioester with a synthetic peptide containing an N-terminal Cys, resulting in a standard amide bond-containing protein backbone (Muir et al., 1998) . With the requisite Akt1 phosphoforms in hand, we performed a combination of experiments that establish a new understanding of how Akt1 regulation occurs.
RESULTS

Production and Characterization of Full-Length Akt1 Semisynthetic Proteins
Expressed protein ligation was performed by generating recombinant Akt1 protein (aa1-459 or aa144-459) carrying a C-terminal thioester and reacting it with N-Cys synthetic phospho-peptides (aa460-480) (Figure 1 ). The recombinant Akt1 segments were expressed in SF9 insect cells resulting in Akt1-intein-CBD (chitin binding domain) fusion proteins (Bolduc et al., 2013) . To install phosphorylation at Thr308, we co-expressed PDK1 and Akt1 while treating cells with phosphatase inhibitor (Fabbro et al., 1999; Kumar et al., 2001) or used recombinant PDK1 to phosphorylate the Akt1 thioester fragments in vitro. Both worked efficiently, netting what appeared by western blot to be stoichiometric pThr 308 ( Figure 1 ). Note that by performing the PDK1
phosphorylations on the C-terminally truncated forms of Akt1, where Akt1 exists in an inactive state (Yang et al., 2002b) and therefore autophosphorylation is expected to be minimal, Figure 1 . Semisynthesis of Site-Specifically Phosphorylated Akt1 Constructs (A) Semisynthesis strategy for C-terminally phosphorylated Akt1 proteins with highlighted phosphorylations (red balls) that are studied in this work. C-terminally truncated recombinant Akt1 containing PDK1-catalyzed pThr 308 and a C-terminal intein generated thioester is ligated to N-Cys synthetic C-tail peptides without or with phosphorylations at residues Ser473, Ser477, and Thr479. S1 and S2 and Tables S1 and S2. precise control of C-terminal phosphorylation of Akt1 is achieved. Akt1 lacking significant levels of phosphorylation at Thr308 (<5%) was obtained by omitting PDK1 transfection.
Chemoselective ligations of the aa460-480 N-Cys synthetic phospho-peptides to the requisite recombinant Akt1 MESNA thioester proceeded smoothly (>90%) and produced a full slate of pThr 308 and non-pThr 308 full-length semisynthetic Akt1s
(aa1-480) and a subset of aa144-480 Akt1 forms with various combinations of C-terminal phosphorylations or Asp473. It should be noted that because Akt1 contains a Cys460 at the ligation junction, the natural Akt1 amino acid sequence was preserved. Gel filtration and anion exchange chromatography of the semisynthetic Akt1s led to purified proteins and demonstrated that each is a monomer. In addition to Coomassie staining of SDS PAGE, western blot with anti-pSer antibodies supported the appropriate phosphorylation status of the target proteins ( Figure 1D ). We also showed that these proteins were phosphorylated at Thr450, a fold-sta- bilizing site, presumably incorporated during SF9 cell expression ( Figure S1A ).
Enzymatic Analysis of Full-Length Akt1 Semisynthetic Proteins
To assess the catalytic properties of the semisynthetic full-length Akt1 forms, we adopted a radioactive assay which measures the incorporation of 32 P into a GSK3 peptide substrate (Tarrant et al., 2012; Yang et al., 2002a; Zhang et al., 2006) and showed activity was linear with respect to time and Akt1 concentration in these assay conditions (Figures S1B-S1E). We then measured the k cat and ATP K m values as well as the apparent GSK3 peptide K m values as shown in Figure 2 . Comparing the catalytic efficiencies (k cat /K m ) for the pThr 308 set of Akt1s ( Figure 2B ) revealed that pThr 308 /pSer 473 (A1) was $500-fold greater than that of the non-C-terminally phosphorylated Akt1 (A2) and this resulted from a higher k cat and reduced K m for ATP, although the apparent peptide substrate K m s were similar. Of note, the Asp473 (A4), pSer 477 (A7), and pThr 479 (A8) forms showed quite low k cat /K m s that were within 3-fold of that of the non-C-terminally phosphorylated enzyme, A2 ( Figure 2B ). The catalytic similarity of the Asp473 (A4) and the non-C-terminally phosphorylated (A2) forms relative to the much greater kinase activity of pSer 473 (A1) was surprising because Asp473 has been suggested to be a phospho-mimetic in Akt1 (Alessi et al., 1996) . We also assessed the catalytic effects of combinations of the C-terminal phosphorylations and noted that the triply phosphorylated C-tail form (A5) was slightly ($2-fold) more active than pSer473 (A1). Interestingly, Akt1 containing both non-canonical C-terminal phosphorylations (pSer 477 /pThr 479 , A6) showed a robust k cat , comparable to that of A1 but an elevated K m for ATP and an overall 8-fold lower catalytic efficiency relative to A1. These results suggest that dual phosphorylation of Ser477 and Thr479 can synergize to promote Akt1 catalysis. In addition, we measured the sensitivity of A1 and A6 to the ATP-site Akt inhibitor GDC0068 (Blake et al., 2012) . Interestingly, A1 displayed an 8-fold lower apparent K i for GDC0068 relative to that of A6, indicative of a perturbed ATP binding pocket in A6 (see Figures S1F and S1G).
Akt1 forms lacking phosphorylation at Thr308 showed marked reductions in kinase activity ( Figure 2B ) with 500-fold reduced catalytic efficiency when comparing the pSer473 form (A3) to A1 or $1,500-fold when comparing completely unphosphorylated enzyme (A9) to A1 ( Figure 2B ). Therefore, C-terminal phosphorylation and activation loop phosphorylation in Akt1 show independent and synergistic effects in the regulation of Akt1, as reported previously (Alessi et al., 1996) .
To assess whether C-terminal phosphorylation of Akt1 could influence the rate of Thr308 phosphorylation by PDK1, we ran a time course that monitored the appearance of pThr 308 by western blot (Figures S2A and S2B) . These experiments showed that pSer 473 and to a lesser extent pSer 477 and pThr 479 enhance the rate of pThr 308 appearance and combinations showed a maximal effect of $5-fold ( Figure S2C ). These results suggest that should C-terminal phosphorylation of the Akt1 precede Thr308 phosphorylation, it could promote PDK1-mediated activation. Fluorescence binding studies with PDK1 showed that its K d for engaging the non-C-terminally phosphorylated Akt1 (0.2 mM) Figure 2A and the enzymatic parameters are shown in Figure 2B . ( See also Figure S3 and Table S3 .
was actually $2-fold lower than for binding to pSer 473 Akt1 ( Figure S2D ). These results imply that the basis for enhanced PDK1 action on C-terminally phosphorylated Akt1 stems from a more optimized orientation for catalysis rather than a tightening of affinity between the two kinases ) ( Figure S2E ).
Structural and Enzymatic Analysis of N-Terminally Deleted (D143) Akt1 Forms
Given the major differences in catalytic efficiencies of A1 and A5 versus A2 and A4, we pursued the X-ray crystal structure of the C-terminally phosphorylated forms in the context of the Akt1 catalytic domain (D143-Akt1) as S473D D143-Akt1 had been successfully crystallized previously (Yang et al., 2002a) . Initial attempts to obtain high quality crystals of C-terminally phosphorylated D143-Akt1 in complex with GSK3 peptide substrate (GRPRTTSFAE) and AMPPNP were unsuccessful. To facilitate co-crystallization, we synthesized an ATP-peptide conjugate bisubstrate analog (Cheng et al., 2006) designed to inhibit Akt1. We showed that this GSK3 peptide-ATP conjugate could potently inhibit Akt1 kinase activity (apparent K i 3.6 mM) and were able to determine the X-ray structure of D143-Akt1-pThr 308 /3p-Ser Table S3 ; PDB: 6BUU). To our surprise, this protein structure proved extremely similar to that of the previously reported D143-Akt1-pThr 308 / Asp473 (PDB: 4EKK) ( Figure 3C ) with the root-mean-square deviation (RMSD) <0.58 Å between these structures ( Figure 3C ). In particular, the phosphate of pSer 473 and the carboxylate of Asp473 made nearly identical hydrogen bonds to Gln218 in the N-terminal lobe of the kinase domain ( Figure 3C ) (Calleja et al., 2009) . The pThr 479 in our structure was not observed and the pSer 477 appeared to be surface exposed ( Figure S3D ). 473 . We thus prepared the Akt1 form A10 in which the basic patch aa142-144 is replaced with three Ala residues and also the Q218A Akt1 mutant A11 ( Figure 2B ) to probe the interaction between pSer 473 and Gln218. The catalytic efficiencies of A10 and A11 showed major reductions, 50-fold and 150-fold, respectively, rendering the activities similar to that of the non-C-terminally phosphorylated form A2 ( Figures 2B and 3D ). These results suggest that the proposed basic patch and Gln218 interactions with pSer 473 are critical for Akt1 activation.
PIP3 Interactions with Semisynthetic Akts
Because of the importance of the C-terminal modifications in the full-length, but not N-terminally deleted, Akt1 proteins for catalytic activation, we suspected that intramolecular autoinhibition by the PH domain was antagonized by C-terminal phosphorylations. To further probe Akt1 activation mechanisms, we measured the apparent affinity of a soluble PIP3 analog (di-C6-PIP3) with Akt1 forms using a fluorescence anisotropy assay ( Figure S4A ). This analysis demonstrated that the K d values of soluble PIP3 for the pSer473 form (A1) is $0.2 mM, nearly identical to that of non-C-terminally phosphorylated form A2 ( Figures S4C and S4D ). Interestingly, PIP3 shows slightly tighter binding (K d 0.09 mM) to the non-phosphorylated Akt1 form A9 ( Figure S4B ). It has been reported that vesiclecontaining PIP3 and PI(3,4)P2 can stimulate the catalytic activity of Akt in vitro (Ebner et al., 2017) . We confirmed high-affinity soluble PI(3,4)P2 binding to the Akt1 PH domain ( Figure S5D ). However, in our hands, soluble PIP3, soluble PI(3,4)P2, and vesicle-embedded PIP3 did not stimulate the enzymatic activity of non-C-terminally phosphorylated Akt1 (A2) ( Figure S4E ). One theoretical difficulty in analyzing PIP3's effects on kinase activity is the potential for PIP3 to be sequestered by Mg that is added in large excess in kinase assays (Ebner et al., 2017) . We probed for the possibility of soluble PIP3 sequestration by Mg using fluorescent binding assays and found that Mg addition up to 10 mM only had a modest effect on PIP3 binding to the Akt1 PH domain, increasing the K d $3-fold ( Figure S5B ). Because the PIP3 concentration that we used was still far above this K d level, we deduce that PIP3 occupancy of the Akt1 PH domain per se does not induce Akt1 activation.
Crystal Structure of D122 C-Terminally Phosphorylated Akt1
We next determined the X-ray structure of an intermediate length Figure S3G ). These results provide direct evidence in support of an important role for the basic patch residues aa142-144 binding to pSer 473 in the tail.
To further test this model, we generated the R144A point mutation in the context of pSer 473 Akt1 (A12) ( Figure 2B ) and found that A12's catalytic efficiency is $50-fold below the wild-type WT version A1, similar to that of the Q218A (A11) and basic patch mutant (A10) forms ( Figure 2B ). These results corroborate the X-ray crystallographic findings that the electrostatic interaction between the side chains of Arg144 and pSer 473 are key in Akt1 kinase activation.
Cellular Analysis of the Akt1 Linker Basic Patch Mutant
To understand the physiological significance of the role of the linker aa142-144 basic patch and Arg144 in Akt1 activation, we investigated the role of these residues in cell transfection experiments. We employed human HCT116 colon cancer cells in which Akt1 and Akt2 were genetically deleted (Ericson et al., 2010) and confirmed that WT transfected full-length Akt1 confers response to growth factors as assessed by Foxo1a/3 phosphorylation (Figures 4A and 4B) (Ericson et al., 2010) . In contrast, transfected Akt1 possessing the basic patch 142-AAA-144 mutation showed diminished Foxo1a/3 phosphorylation (Figures 4A and 4B) . Interestingly, basic patch mutant Akt1 also displayed a loss in growth factor-mediated Ser473 phosphorylation relative to WT Akt1 (Figures 4A and 4B) . To determine whether the reduction in Ser473 phosphorylation of the basic patch AAA mutant Akt1 was somehow an indirect effect of its lower Akt1 catalytic activity, we investigated D274A Akt1 in which the active site base Asp274 side chain is replaced (Ebner et al., 2017) . We observed that D274A Akt1 showed robust Ser473 phosphorylation after cells were growth factor-treated ( Figures S6A  and S6B ), however, Foxo1a/3 phosphorylation was reduced (Figures S6A and S6B) . Therefore, reduced Akt1 Ser473 phosphorylation in the setting of R144A is not simply related to a general reduction in kinase activity associated with R144A but was likely related to the specific loss of the salt bridge between Arg144 and pSer 473 . This salt bridge disruption presumably shifts the equilibrium of pSer 473 Akt1 to a conformation that exposes pSer 473 , subjecting it to phosphatase cleavage ( Figure 4A ). R144A Akt1 also showed diminished pSer 473 in response to growth factors (Figures S6C and S6D) . Because Arg144 is part of the linker between the PH and kinase domains, we hypothesized that the linker length and/or conformation could be important in tuning the pSer 473 -basic patch interaction to counteract the PH-mediated autoinhibition of the kinase domain ( Figure 5A ). Consequently, we designed an Akt1 form in which six Gly residues are inserted into the center of the PH-kinase linker of Akt1 (123-Gly-6xGly-Ser-124 Akt1) (Chen et al., 2017) . By inserting the hexa-Gly segment, it was presumed that potential change in linker tension induced by pSer473-Arg144 and its tug on the PH domain would be relieved. In cellular experiments with transfected Gly6-Akt1, it was found that pFoxo1a/3 and pSer 473 were both diminished relative to WT Akt1 transfected cells. These results support the notion that pSer 473 may influence Akt1 PH-kinase linker tension to loosen PH domain-mediated autoinhibition. In contrast, with the hexaGly insertion, the conformational equilibria would favor the autoinhibited PH-kinase domain state even after phosphorylation of Ser473 in Akt1 ( Figures 5B-5D ) that would ultimately trigger hydrolysis of pSer 473 by cellular phosphatases.
Mechanism of Akt1 Activation by Ser477/Thr479 Dual Phosphorylation
In contrast to the mutagenesis effects of the linker basic patch (A10) and Gln218 (A11) on the kinase activity of pSer 473 , the effects of these mutations (A13, A14) on pSer 477 , pThr 479 Akt1
were minor (k cat /K m s of A6 versus A13 and A14 are within $2-fold, Figure 2B ). These results suggest that the structural basis of Akt1 activation by dual phosphorylation of Ser477 and Thr479 is distinct from that of phosphorylation of Ser473. , that replaces Phe472 with the analog benzoylphenylalanine (Bpa) (Chen et al., 2016; Herblin et al., 1987) . Bpa is a photo-activatable amino acid that can covalently cross-link residues to map intramolecular protein interactions (Chen et al., 2016; Herblin et al., 1987) . To enrich for C-terminal cross-linked peptide, we incorporated Lys-biotin in place of His468 (468K Bio ) and found that UV exposure of this BpaAkt1 form followed by liquid chromatography-tandem mass See also Figures S3, S4 , S5, and S6 and Table S3. spectrometry (LC-MS/MS) analysis led to one cross-linked peptide with a significant Crossfinder score (>500) (Mueller-Planitz, 2015) . This cross-linked peptide (Crossfinder score 1933) was composed of the modified C-terminal segment of Akt1 (aa466-480) and a short fragment of the activation loop (302-DGATMK-307) (Figures 7 and S7) and its formation was dependent on UV exposure (Tables S4 and S5 ). Structural assignment of this unique cross-link was further confirmed using microchip capillary electrophoresis (ZipChip-CE) electron transfer dissociation (ETD) MS/MS. Based on X-ray structure analysis, the activation loop conformation in the activated form of Akt1 and the PH domain in the autoinhibited structure of Akt1 clash and should be mutually exclusive in the catalytically active conformation of Akt1 ( Figures S3E and S3F ). Thus, if the pSer477/pThr479 tail sits near the activation loop in its catalytically competent conformation as indicated by the photo-cross-linking, this should displace the PH domain from the kinase domain and relieve autoinhibition. A cartoon model for this mechanism, that also reflects (B) Cellular assays for an Akt construct in which a hexa-Gly (6G) segment is inserted into the PHkinase linker compared with wild-type Akt1. Assays were carried out as described in Figure 4A .
(C) Quantification of the phosphorylation level of Ser473 (blue for WT Akt1 and purple for 6G-Akt) and Foxo1 Thr24/Foxo3a Thr32 (pink for WT Akt1 and yellow for 6G-Akt1) from three replicates (n = 3, SEM shown, p < 0.01).
(D) Cartoon depicted shows the model for the effect of a hexa-Gly insertion into the Akt1 PH-linker. The 6 Gly insertion is proposed to enhance linker flexibility stabilizing the intramolecular PH-kinase interaction even after C-terminal phosphorylation of Akt1 on Ser473. See also Figure S6 .
a presumed contact of the tail near the PH domain with its diminished PIP3 affinity, is illustrated in Figure 7C .
DISCUSSION
A principal finding of these studies is that C-terminal phosphorylations on Akt1 can operate outside of the N lobe of the kinase domain to activate Akt1 catalytic activity. These results contrast models from prior studies on Akt and other AGC kinases (Leroux et al., 2018; Pearce et al., 2010) . Our results also do not support the idea that the PH domain engagement by a PIP3 molecule directly relieves PH-mediated autoinhibition as proposed by Ebner et al. (2017) . We think that our findings may differ from this recent study because we employed site-specifically modified Akt1 forms, a direct kinase assay that measures phospho-peptide product (rather than ADP formation), and optimal Mg concentration. Our findings indicate that PIP3's activation of Akt in cells is likely due to the well-documented recruitment of Akt to PIP3 to membranes to facilitate PDK1 and mTORC2 catalyzed activation loop and C-terminal phosphorylation. Interestingly, the PIP3 affinity of pThr 308 Akt1 is 2.5-fold weaker compared with the unmodified activation loop form of Akt1 ( Figure S4 ). This affinity difference can be rationalized based on a comparison of the unmodified PH-kinase and pThr 308 kinase domain X-ray crystal structures where the activation loop phosphate would clash with the PIP3 binding cavity on the PH domain ( Figures S3E and S3F ). Perhaps Thr308 phosphorylation can help eject Akt from membranes.
We find that C-terminal phosphorylation of Akt1 can enhance PDK1 phosphorylation of Akt1's activation loop. Structurally, this may be explained by the presumed conformational change which brings the C-terminal PIFtide motif closer to Thr308 . From a functional perspective, these data suggest that C-terminal Akt phosphorylation can stimulate activation loop phosphorylation without the requirement of membrane interactions.
The discovery that the PH-kinase linker plays a direct and critical role in activation by Ser473 phosphorylation may help explain how PTMs on the linker of Akt isoforms including Ser phosphorylation, Cys modification, and Pro hydroxylation may influence Akt regulation (Bellacosa et al., 1998; Guo et al., 2016; Long et al., 2017; Wani et al., 2011) . Such modifications may alter the availability of Arg144 for C-tail interaction through changes in the conformation or tension in the PH-kinase linker.
The distinct Akt mechanisms of activation for pSer 477 Akt1 form (A6) has little impact on kinase activity ( Figure S5A) . Rather, the current data based on PIP3 affinity modulation and photo-cross-linking suggest that the pSer 477 /pThr 479 tail allosterically activates Akt1 kinase activity by binding to the activation loop in proximity to the PH domain ( Figure 7C ). In this model, the PH domain is displaced from the kinase domain, preventing autoinhibition. That A6 shows reduced PIP3 affinity is consistent with an environmental change for the PH domain in this conformation. Moreover, this weakened PIP3 affinity implies that A6 is well-suited to phosphorylate non-membrane-associated protein substrates in the nucleus as previously proposed (Liu et al., 2014 Each product ion is also labeled with its parent sequence (''1'' or ''2'') followed by the charge state of the ion (i.e., 2+). For example, y 1 (2/1+) corresponds to the y 1 ion of peptide 2 singly charged. Specific crosslinked sequences and internal fragments are also indicated (see Figure S7 for the rest of m/z spectrum). ÀH 2 O, water loss; K Bio , biotinylated lysine; B, benzoylphenylalanine. See also Tables S4 and S5 . Fan et al., 2013; Mahajan et al., 2010; Yang et al., 2009 ) in future work.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Akt1/2 knocked-out HCT116 cells (Ericson et al., 2010) were routinely maintained in McCoy's 5A medium (Corning grow) supplemented with 10% FBS and 1% penicillin/streptomycin (GIBCO) at 37 C with 5% CO 2 .
METHOD DETAILS
Peptide synthesis Peptides corresponding to residues 460-480 of Akt1 (CVDSERRPHFPQFSYSASGTA) were synthesized either on a Prelude or PS3 peptide automated synthesizer (Protein Technologies) using the Fmoc strategy and solid phase peptide synthesis and phospho-residues were mono-benzyl protected. In particular, residues were double coupled (1.5 h for standard amino acids and 3 h for phosphoamino acids) and Fmoc groups were removed with 20% (v/v) piperidine in DMF over three 10 min cycles. Biotinylated GSK3 peptide substrate corresponding to residues 14-27 of GSK3(RSGRARTSSFAEPGGK) was synthesized using N-ε-biotin-lysine Wang resin (Iris Biotech).
To synthesize fluorescein labeled peptides, the allyloxycarbonyl (Alloc) protecting group of N-ε-Alloc-lysine was orthogonally removed using 4.4 eq. palladium dissolved in 20:1:0.5-chloroform:dichloromethane:acetic acid for 3 hours. The resin was washed with 0.5% sodium diethyldithiocarbonate trihydrate in DMF, and then 5% 4-methylmorpholine (NMM) in DMF. Subsequently, 1.2 eq. NHS-fluorescein (Thermo Scientific) dissolved in 5% NMM in DMF was added to the resin, and the coupling reaction was left overnight.
Peptides were deblocked and cleaved from resin with trifluoroacetic acid: water: triisopropylsilane (95:2.5:2.5, v/v/v) for 3 hours, then precipitated with chilled diethyl ether and purified using reverse-phase C18 HPLC using a gradient of water:acetonitrile containing 0.1% trifluoroacetic acid. Pure fractions were combined and concentrated on a rotavap and then lyophilized. Peptide structures were confirmed using MALDI mass spectrometry and peptide concentrations were determined by amino acid analysis.
To generate the ATP-GSK3 peptide bisubstrate, the Alloc protecting group from Nb-Alloc-L-2,3-diaminopropionic acid (Sigma) was orthogonally deprotected as described above and then 10 eq. of bromoacetic anhydride (dissolved in 5% NMM in DMF) was added to the resin and the coupling reaction was performed for 3 hours to afford bromo-GSK3 peptide. Bromo-GSK3 peptide was cleaved from the resin as described above and purified using reverse-phase C18 HPLC and lyophilized. Bromo-GSK3 peptide (5 mg) was reacted with 2 eq. of ATP-gamma-S solution (Li salt, Roche) in 250 mL of aqueous buffer containing 100 mM NH 4 HCO 3 , pH 8.0 overnight at room temperature. The conjugation product ATP-GSK3 peptide was purified using reverse-phase C18 HPLC using basic conditions (10%-35% gradient of acetonitrile to water containing 10 mM NH 4 HCO 3 ) and the correct structure confirmed by mass spectrometry. The concentration of the GSK3 peptide-ATP bisubstrate analog was determined using UV spectrometry based on the extinction coefficient of ATP.
Molecular Cloning and Mutagenesis
For the expression of Akt1 (aa1-459, 144-459 or 123-459)-MxeIntein-CBD fusion proteins in insect cells, the human Akt1 gene from pcDNA3-Flag-HA-Akt1 (Addgene, # 9021) was subcloned into a modified pFastBac1 plasmid containing the gyrase MxeIntein and chitin binding domain (CBD). For the expression of 6xHistidine tagged Akt1(123-459)-MxeIntein-CBD fusion protein in E. coli, the Akt1 gene was subcloned into a pTXB1 plasmid. To produce Akt mutants for insect cell expression or mammalian cell-based assays, the QuickChange PCR method (Agilent Technologies) was employed. To generate GST-PDK1, the gene encoding human full length PDK1 (aa1-556) from pcDNA3-PDK1 (Genescript, # OHu59606) was subcloned into pFastBac1 plasmid and then the glutathione S-transferase (GST) tag was N-terminally inserted using a 2-step QuickChange PCR method. All DNA primers used in this work are listed in Table S1 . The open reading frames of all wt and mutant constructs were verified by DNA sequencing.
Expression and purification of GST-PDK1
A pFastBac1 baculovirus vector containing GST-PDK1 fusion protein (PDK1 aa 1-456) was used to make bacmid and then baculovirus in Sf21 insect cells using standard methods (Bolduc et al., 2013) . The resulting baculovirus was used to infect Sf9 insect cells with multiplicity of infection (M.O.I.) of 5.0. After growing in Sf9 III media (GIBCO) for 48 hours at 27 C, the cells were pelleted (700 x g, 10 min, 4 C and then resuspended in 1/20 th of the media used for culture, pelleted again (discarding the supernatant), and then flash frozen in liquid nitrogen and stored at À80 C. The Sf9 cells from 400 mL culture were resuspended in 20 mL lysis buffer (50 mM HEPES pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.5% Triton X-100, 1 mM sodium orthovanadate, 10 mM sodium b-glycerophosphate, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM benzamidine, 0.1% BME, 0.27 M sucrose containing one protease inhibitor tablet (Roche)) (Alessi et al., 1997) and lysed in a 40 mL Dounce homogenizer on ice. The lysate was centrifuged (17,500 x g, 40 min, 4 C) and the supernatant was mixed with 3 mL glutathione resin (Thermo Fisher Scientific) at 4 C. The resin was washed 10 times with storage buffer (50 mM HEPES pH 7.5, 0.1 mM EGTA, 0.1% BME, 0.27 M sucrose) to remove Triton X-100 and then eluted with 50 mM glutathione in storage buffer. The resulting eluate was further purified by size exclusion chromatography using a Superdex 200 column equilibrated with storage buffer and the fractions (> 90% pure using SDS-PAGE and Coomassie blue) were combined and concentrated to 1 mg/ml, aliquoted and stored at À80 C.
Generation of semisynthetic Akt proteins
The baculovirus-insect cell expression system was employed to express the Akt1-Mxeintein-CBD fusion construct (Akt1 aa2-459, 144-459 and 123-459) similarly to that described for GST-PDK1. For protein production, Sf9 insect cells were infected with the respective baculovirus at M.O.I. of 5.0 and cultured in Sf9 III media for 48 hours at 27 C. To obtain in vivo Thr308 phosphorylation, the Akt1(aa2-459)-MxeIntein-CBD fusion construct was co-expressed with GST-PDK1 in Sf9 insect cells with M.O.I.s of 5.0 and 1.0 for the baculovirus containing Akt1 and GST-PDK1, respectively. After growing infected Sf9 cells for $36 hours at 27 C, 25 nM okadaic acid (Cell signaling technology-CST) was added, and the cells permitted to grow for an additional 16 hours and then harvested as described above. In the absence of GST-PDK1 co-expression and okadaic acid, Akt1s produced appeared to be lacking phosphorylation at Thr308 (< 5% by western blot). The cells from 200 mL culture were lysed in a 20 mL Dounce homogenizer in 10 mL lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% Glycerol, 0.1% Triton X-100) containing one dissolved protease inhibitor tablet (Roche). The lysate was centrifuged (17,500 x g, 40 min, 4 C) and the supernatant was added to a 5 mL bed of fibrous cellulose (Sigma). After 1 hour of incubation at 4 C, the lysate was filtered from the cellulose and then bound to 5 mL chitin resin (NEB). The resin was then washed with 150 mL washing buffer (50 mM HEPES pH 7.5, 500 mM NaCl, 0.1% Triton X-100), incubated overnight in cleavage buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 300 mM MESNA (sodium mercaptoethylsulfonate), 1mM phenylmethylsulfonylfluoride (PMSF), 10% glycerol) at room temperature (RT). The cleavage buffer containing Akt thioester protein was eluted from the resin, and concentrated by ultrafiltration using an Amicon 10 KDa molecular weight cutoff (MWCO) filter. The N-terminal Akt1 protein fragments containing a C-terminal thioester were shown to be > 90% pure by SDSPAGE and reacted with the synthetic N-Cys containing C-terminal Akt peptides (CVDSERRPHFPQFSYSASGTA) containing variable phosphorylation (bolded in aa sequence) or Asp473 in ligation buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP, 0.5 mM PMSF, 10% glycerol) for 5 hours at RT and then maintained overnight at 4 C. The ligation conversions were assessed by Coomassie-stained SDSPAGE and typically shown to be greater than 95%. The semisynthetic Akt1 proteins were purified by size exclusion chromatography on a Superdex 200 column (GE Healthcare) with Akt1 storage buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM beta-mercaptoethanol, 0.5mM (PMSF), 0.5 mM sodium orthovanadate, 10% glycerol) where they were shown to be monomeric. The purified fractions (> 95% by Coomassie stained SDSPAGE) were combined, concentrated to $5 mg/ml, aliquoted and then stored at À80 C. For semisynthetic truncated Akt1 constructs (aa 144-480 and aa123-480), a modified protocol involving in vitro GST-PDK1-catalyzed Thr308 phosphorylation was used to improve the Akt1 protein expression level in Sf9 cells. The Akt1 thioester protein (aa 144-459 or aa 123-459) obtained from the MESNA cleavage step was concentrated to 1 mL and treated with 2 mM GST-PDK1, 2 mM ATP in buffer 50 mM HEPES pH 7.5, 150 mM NaCl, 50 mM MESNA, 20 mM MgCl 2 , 10% glycerol, 0.2 mM sodium orthovanadate for 3 hours at room temperature. The reaction mixture was then loaded on glutathione resins to remove GST-PDK1 and then exchanged into the ligation buffer for the Akt1 protein ligation reaction as described above.
To obtain bacterially expressed Akt1 (aa 123-459), the pTXB1 plasmid containing 6xHistidine tagged Akt1 (aa 123-459)-MxeIntein-CBD fusion protein was expressed in E. coli Rosetta (DE3)/pLysS in 1L 2xYT media containing 100 mg/ml ampicillin and 10 mg/ml Chloramphenicol. The cultures were grown in shaker flasks at 37 C until OD600 = 0.5, then 1 mL 0.3 M IPTG was added to induce expression and the cultures were further incubated for 16 hours at 16 C. Cells were pelleted and then resuspended in 20 mL lysis buffer, and lyzed by french press. The lysate was loaded on 5 mL chitin resin and the Akt1 fusion protein was purified with chitin resin as described above. The Akt1 protein was cleaved off from the resin with the cleavage buffer containing 100 mM DTT at room temperature overnight.
Kinase assays
The kinase parameters of semisynthetic Akt constructs were determined by phosphorylating N-ε-biotin-lysine GSK3 peptide (RSGRARTSSFAEPGGK) in radiometric reactions as previously described (Qiu et al., 2009) . Radiometric kinase assays were carried out in small plastic tubes in a 25 mL reaction mixture containing 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 1 mM EGTA, 2 mM DTT, 1 mM sodium orthovanadate, 0.5 mg/ml BSA (kinase reaction buffer), 0.42 mCi 32 P-g-ATP and varying amounts of biotinylated GSK3 peptide substrate (0-20 mM) and ATP (0-2 mM). Reactions were initiated by the addition of Akt1 (0-500 nM) and were typically performed at 30 C for 10 minutes. The kinase reactions were quenched by adding 20 mL of 100 mM EDTA and then 10 mL of 10 mg/ml Pierce avidin (Thermo Scientific) was added to each sample and incubated for 20 minutes at room temperature. Samples were transferred to centrifugal 30 KDa MWCO filtration units (Nanosep 30K, PALL) and washed two times with 100 mL and one time with 120 mL of washing buffer (0.5 M sodium phosphate, 0.5 M NaCl, pH 8.5). The filtration units were placed in 5 mL scintillation fluid and then beta emission measured using a Beckman liquid scintillation counter (Beckman LS6500). Background levels without Akt1 or peptide substrate were in the range of 500-1000 cpm and with points including enzyme and substrate were more than 2-fold above background. All measurements were made at least twice and replicates were typically within 20%.
Anisotropy measurements
To determine binding affinity of Akt1 constructs with GST-PDK1, different concentrations of GST-PDK1 were mixed with 0.4 mM of semisynthetic Akt constructs C-terminally labeled with fluorescein in binding buffer (50 mM HEPES pH 7.5, 2 mM DTT, 10 mM MgCl 2 ) and with or without 1 mM AMP-PNP and incubated at room temperature for 30 minutes. For binding assays of Akt1 constructs with PIP3, different amounts of Akt1 were mixed with 50 nM fluorescein-labeled soluble PIP3 (Cayman Chemical) in binding buffer (50 mM HEPES pH 7.5, 2 mM DTT, 0.05 mg/ml ovalbumin) and incubated at room temperature for 30 minutes. Fluorescent anisotropy spectra were recorded by Fluoromax 3 system (Horiba) at 23 C with three different replicates. The K d values were determined by fitting the data to the quadratic binding equation below: (Seamon et al., 2015; Weiser et al., 2017) with X is ligand concentration and Y is anisotropy unit.
All measurements were made at least twice and replicates were typically with 20%. The competition binding assays in which fluorescein-labeled soluble PIP3 was displaced from Akt PH domain by unlabeled soluble PIP3 (di-C6) or PI(3,4)P2 (di-C8) were performed as previously described (Weiser et al., 2017) . 50 nM of fluorescein-labeled PIP3 was incubated with 1 mM Akt PH domain and varied concentrations of the corresponding competitors in binding buffer at room temperature for 30 minutes, then fluorescence anisotropy measurements were performed as described above. The data were fit with a sigmoidal curve to determine IC 50 values. The obtained IC 50 values were used to calculate affinity binding (Ki) using the equation:
where L50 is the concentration of free fluorescein-labeled PIP3 at 50% inhibition, P 0 is the concentration of free Akt PH domain at 0% inhibition, and K d is dissociation constant of the fluorescein-labeled PIP3-Akt PH complex (Weiser et al., 2017) .
Activation assays 1 mM Akt was mixed with 10 nM GST-PDk1 in activation buffer 50 mM HEPES, pH 7.5, 2 mM DTT, 10 mM MgCl 2 and incubated at 30 C, the reaction was triggered by adding 1 mM ATP. 10 mL of the reaction was collected at the indicated time points and quenched by the addition of 4xSDS-loading buffer. The SDS samples were loaded on SDSPAGE gel for Western Blot analysis and imaged with anti-pT308 or pan-Akt primary antibodies.
Western blots
After transfers of protein from SDSPAGE gels to membranes using an iBlot system, the membranes were blocked overnight in 50 mg/ml BSA in TBS-T buffer at 4 C. Membranes were incubated with anti-Akt (pan or phospho) primary antibodies (CST) at a 1:5000 dilution overnight at 4 C, washed 3 times of 10 minutes with TBS-T buffer, and the cycle of antibody incubation and washing was repeated with secondary HRP-linked antibody (CST). Membranes were developed with Amersham ECL western blotting detection reagents (GE Healthcare) and imaged by a GeneSys imaging system. Crystallization Semisynthetic Akt1 (aa144-480) protein with pThr 308 and C-terminal triple-phospho residues Ser473, Ser477, Thr479 (10 mg/ml) was mixed with 1 mM ATP-GSK3 bisubstrate peptide and 1 mM MnCl 2 . Crystals were grown at 4 C with 20% PEG3000, 0.2 M ammonium sulfate, 0.1 M HEPES pH 7.5 by vapor diffusion in sitting drop 24-well plates with a 1:1 volume ratio of protein to crystallization buffer for 4 days.
Semisynthetic Akt1 (aa123-480) protein with pThr 308 and C-terminal triple-phospho residues Ser473, Ser477, Thr479 (10 mg/ml) was mixed with 1 mM ATP-GSK3 bisubstrate peptide and 1 mM MnCl 2 and crystallized at 4 C with 12.5% PEG3350, 0.2 M ammonium acetate, 0.1 M HEPES pH 7.5 by using sitting drop 24-well plates and a 1:1 volume ratio of protein to crystallization buffer for 1 week.
All crystals were cryoprotected in the same precipitant buffers that they were grown with 20% (v/v) of 50% PEG solution added, flash frozen and stored in liquid nitrogen until submitted to X-rays and data collection.
Data collection and structural determination
Diffraction data of Akt1 (aa144-480) in complex with ATP-GSK3 bisubstrate peptide were collected on a FR-e Super-Bright Rigaku (Americas Corporation, The Woodlands, TX) copper rotating anode X-ray generator as the source with a DECTRIS Pilatus 3R 200K-A detector at 100 K. Data were indexed, integrated and scaled with HKL3000 ( Otwinowski and Minor, 1997) . The structure of Akt1 (144-480) in complex with ATP-GSK3 bisubstrate peptide was determined by molecular replacement using the program AMoRE and S473D Akt1(aa144-480) (PDB ID 4EKK) (Lin et al., 2012) as initial template (Navaza, 2001) . The model was rebuilt manually with interactive rounds of Coot and refined using refmac5 from the CCP4 suite. The final structure, PDB ID6BUU, was refined to 2.4 Å (Murshudov et al., 1997; Winn et al., 2003) .
Diffraction data of Akt1(aa 123-480) in complex with ATP-GSK3 bisubstrate peptide were collected at National Synchrotron Light Source II (Brookhaven, NY) beam line 17-ID1on a DECTRIS Eiger 6M detector. Data were reduced with fastdp, aimless (Kabsch, 2010a (Kabsch, , 2010b Winter and McAuley, 2011) . The Akt1 (aa123-480) in complex with ATP-GSK3 bisubstrate peptide was determined by molecular replacement using PDB 6BUU as template. The initial models were rebuilt and refined as described above for PDB 6BUU. The final structure of Akt1 (aa123-480), PDB 6CO1, was refined to 2.1 Å . Final models were validated using Coot (Emsley et al., 2010) , Molprobity (Chen et al., 2010) . Structure figures were prepared with PyMOL (DeLano, 2002; Schrö dinger, 2015) . RMSD between models were calculated using the LSQ function in Coot.
Mammalian cell signaling analysis Akt1/2 knocked-out HCT116 cells (Ericson et al., 2010) were routinely maintained in McCoy's 5A medium (Corning grow) supplemented with 10% FBS and 1% penicillin/streptomycin (GIBCO) at 37 C with 5% CO 2 . When the cells reached $70% confluence in 6-well plates, the cells were transfected with 1.5 mg of pcDNA3.1-Flag-HA-Akt plasmids complexed with 3 mL Lipofectamine 3000 and 3 mL P3000 reagent in Opti-MEM medium for 24 hr at 37 C and 5% CO 2 . When indicated, the cells were rinsed twice by PBS and serum-starved for 18hrs in McCoy's 5A with 0.5% FBS and stimulated with 100 ng/ml of insulin (ThermoFisher Scientific), 60 ng/ml of EGF (CST) and 60 ng/ml human IGF-1 (CST) for variable times (5, 10, 20, and 40 minutes) at 37 C and 5% CO 2 . The cells were lysed by adding 80 mL RIPA buffer (CST) containing 1x complete protease inhibitor tablet and 1 mM PMSF, and shaking for 30 minutes at 4 C. 30 mg of total protein (BCA assay) was loaded on SDSPAGE. Membrane transfer and western blotting was carried out as described above with 1:1000 dilution for primary antibodies: Akt, phospho Akt, FOXO1, FOXO3a; 1:200 dilution for phospho FOXO1/3a, and 1:5000 dilution for anti-b-actin antibody.
UV-induced protein crosslinking
The di-pSer 477 /Thr 479 Akt C-tail peptide with replacements of Phe472 by Benzoylphenylalanine (Bpa) and of His468 by N ε -biotinylated Lysine was synthesized and ligated to truncated pThr 308 -Akt thioester as described above. The UV-induced cross-linking reaction was performed with 60 mg of Akt diluted in buffer 50 mM Tris-HCl pH7.8, 10 mM DTT, and UV-irradiated at 365 nm for 3 hr in a quartz reaction vessel with circulating water at 4 C and constant stirring. Next, the UV-irradiated Akt was treated with 1 mM bovine alkaline phosphatase (Sigma Aldrich) for 2 hr at room temperature, followed by reduction with 5 mM TCEP in 50 mM NH 4 HCO 3 for 30 minutes at 60 C, and alkylation with 10 mM 2-chloroacetamide for 30 minutes at room temperature in the dark. The Akt protein sample was desalted using Protein Desalting Spin Columns (Thermo Scientific), and digested with 2% (wt/wt) trypsin for 16 hr at 37 C. The tryptic digestion was stopped by adding TFA to 0.1% (v/v) final concentration, then desalted using C-18 spin columns (Thermo Scientific) and lyophilized. The dried peptides were reconstituted in PBS buffer, pH 7.4 for enrichment of biotinylated peptides using monomeric avidin agarose (Thermo Scientific). The biotinylated peptides were eluted from the avidin agarose with 2 mM d-Biotin in PBS buffer, and desalted using C-18 spin columns, lyophilized and stored until mass spectrometry analysis.
Nano LC-MS Analysis
The biotinylated peptides from crosslinking were reconstituted in 20% acetonitrile, 0.1% formic acid with 50 mM guanidine HCl and analyzed by nano LC-MS using a NanoAcquity UPLC system (Waters, Milford, MA) interfaced to a QExactive HF mass spectrometer (Thermofisher Scientific, San Jose, CA) (Ficarro et al., 2009 ). Peptides were injected onto a self packed pre-column (4 cm POROS 10 R2, Applied Biosystems, Framingham, MA) and gradient eluted (10%-70% B in 40 minutes; A = 0.2 M acetic acid in water, B = 0.2 M acetic acid in acetonitrile) to an analytical column (30 um I.D., packed with 50 cm Monitor C18, Column Engineering, Ontario, CA) with integrated ESI emitter tip (spray voltage = 3 kV). The mass spectrometer was operated in data-dependent mode, where the 10 most abundant ions in each MS scan (120K resolution, 3E6 target, lock mass enabled = 445.120025) were subjected to MS/MS (15K resolution, 2E5 target, 100 ms max fill time). Dynamic exclusion was enabled with a repeat count of 1 and an exclusion time of 30 s. Raw MS/MS data were converted to mzXML using multiplierz (Alexander et al., 2017; Parikh et al., 2009 ) and MS/MS spectra matched to peptide sequences with Crossfinder version 1.1 (Mueller-Planitz, 2015) . The Crossfinder data are complied in Tables  S4 and S5 . Crossfinder hits were validated using mzStudio (Ficarro et al., 2017) .
CE-MS Analysis
The biotinylated peptides from crosslinking were reconstituted in 50% acetonitrile, 1% formic acid with 100 mM ammonium acetate and analyzed by CE-MS using a ZipChip CE system and autosampler (908 Devices, Boston, MA) interfaced to an Orbitrap Lumos mass spectrometer (ThermoFisher Scientific). Peptide solutions were loaded for 30 s and separation performed at 500 V/cm for 10 minutes using an HR chip (22 cm separation channel) with a background electrolyte composed of 1% formic acid in 50% acetonitrile. Pressure assist was utilized and started at 1 minute. The mass spectrometer was programmed to perform continuous MS1 (15K resolution, 1E6 target) and targeted MS2 (quadrupole isolation, 2 Da isolation window, ETD dissociation with charge calibrated parameters, 250 ms max fill time, 5E5 target, FTMS detection with 15K resolution) scans.
Preparation of phospholipid vesicles
The DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) phospholipid small unilamellar vesicles with 5 mol % of bulk PIP3 (1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3 0 ,4',5 0 -trisphosphate) (Avanti Polar Lipids) were prepared as previously described (Chu et al., 2014) . Briefly, 5 mg of phospholipid DOPC and 100 mg of bulk PIP3 were dissolved in 1 mL of chloroform in a 10 mL round bottom flask, and chloroform was removed by nitrogen flow to form a thin lipid film. Next, the film was hydrated in 50 mM HEPES, pH 7.5 for 1 h with vortexing every 10 minutes in between. The lipid mixture was subjected to 5 cycles of freezing with dry ice-methanol followed by thawing with cool tap water and then under warm (42 C) water for 30 s. The lipid solution was passed 20 times through a mini-extruder with a 100-nm polycarbonate membrane (Avanti Polar Lipids). The resulting vesicles were collected and kept under argon at 4 C for the next steps.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters are reported in the figure legends and in the STAR Methods. All the biochemical assays were repeated at least twice. The western blots for cell transfection studies were repeated at least thrice. The bands were quantified using ImageJ software, and the error bars represent the SEM.
DATA AND SOFTWARE AVAILABILITY
The accession number for the atomic coordinates and structure factors for the Akt1 (144-480) in complex with ATP-GSK3 bisubstrate peptide reported in this paper is PDB: 6BUU. The accession number for the atomic coordinates and structure factors for the Akt1 (aa123-480) in complex with ATP-GSK3 bisubstrate peptide reported in this paper is PDB: 6CO1. Raw and analyzed data for this paper have been deposited to Mendeley Data: https://doi.org/10.17632/8d5hgmvhjm.1.
